via University of Exeter
A new tool which could help reduce the spread of antimicrobial resistance is showing early promise, through exploiting a bacterial immune system as a gene editing tool.
Antimicrobial resistance is a major global threat, with nearly five million deaths annually resulting from antibiotics failing to treat infection, according to the World Health Organisation.
Bacteria often develop resistance when resistant genes are transported between hosts. One way that this occurs is via plasmids – circular strands of DNA, which can spread easily between bacteria, and swiftly replicate. This can occur in our bodies, and in environmental settings, such as waterways.
The Exeter team harnessed the CRISPR-Cas gene editing system, which can target specific sequences of DNA, and cuts through them when they are encountered. The researchers engineered a plasmid which can specifically target the resistance gene for Gentamicin – a commonly used antibiotic.
In laboratory experiments, the new research, published in Microbiology, found that the plasmid protected its host cell from developing resistance. Furthermore, researchers found that the plasmid effectively targeted antimicrobial resistant genes in hosts to which it transferred, reversing their resistance.
Lead author David Walker-Sünderhauf, of the University of Exeter, said: “Antimicrobial resistance threatens to outstrip covid in terms of the number of global deaths. We urgently need new ways to stop resistance spreading between hosts. Our technology is showing early promise to eliminate resistance in a wide range of different bacteria. Our next step is to conduct experiments in more complex microbial communities. We hope one day it could be a way to reduce the spread of antimicrobial resistance in environments such as sewage treatment plants, which we know are breeding grounds for resistance.”
Original Article: Gene editing tool could help reduce spread of antimicrobial resistance
More from: University of Exeter
The Latest Updates from Bing News
Go deeper with Bing News on:
Antimicrobial resistance
- Poor Regulations, Ignorance Fueling Anti-Microbial Resistance In Nigeria - Prof. Manga
Professor Muhammad Manga is a professor of clinical microbiology and provost of the College of Medical Sciences at the Gombe State University (GSU), Gombe. He also works with the Federal Teaching ...
- Belgian presidency calls for coordinated action against antimicrobial resistance
How do you envisage the creation of a product which you ideally don’t want to use? That was the focal point of the Belgian presidency’s high-level meeting on how the EU should coordinate its response ...
- Moph Hosts Seminar On Antimicrobial Resistance
The Ministry of Public Health hosted a public health seminar entitled 'Antimicrobial Resistance: A Growing Emergency for t ...
- Antimicrobial Resistance Market Will Reach USD 9.5 billion By 2032 And registering a CAGR of 7.6%.
The global antimicrobial resistance market was valued at $4.6 billion in 2022, and is projected to reach $9.5 billion by 2032, registering a CAGR of 7.6% from 2023 to 2032.The growth of antimicrobial ...
- Antimicrobial resistance: UK’s five year plan aims to reduce antibiotic use by 5% by 2029
The government has committed to drive down antibiotic use in the UK, improve surveillance for drug resistant infections before they emerge, and incentivise research into new drugs and vaccines. Its ...
Go deeper with Bing News on:
CRISPR-Cas9 gene editing,
- Crispr Therapeutics Q1 Earnings: Casgevy Launch Tip Of Gene Editing Iceberg
Crispr Therapeutics AG shows potential for future earnings with its gene editing therapy Casgevy, offering treatment for various diseases. Read more here.
- CRISPR gene editing trial treats inherited blindness
Scientistse have restored vision and hearing in people born with congenital blindness or deafness in two seperate gene therapy trials A British toddler born deaf has become the first person to have ...
- Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness
A newer technology makes use of gene editing with the injection of EDIT-101. It is based on the use of clustered regularly interspaced short palindromic repeats (CRISPR) coupled with the ...
- CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach
ASGCT presentation demonstrates lipid nanoparticle (LNP) mediated delivery to the eye in the context of editing of the myocilin (MYOC) gene as a potential treatment for glaucoma - - Expands pipeline ...
- CRISPR Gene Editing Therapy Improved Vision in Trial for Inherited Blindness
CRISPR-Cas9 is a gene editing toolkit that acts as a GPS-guided scissor to cut a portion of the mutated genome to leave a functional gene. For inherited blindness, the goal was to inject CRISPR to ...